ACS Biomarker Overview

  • Founded
  • 2007
Founded
  • Status
  • Out of Business
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Out of Business

ACS Biomarker General Information

Description

Developer of novel biomarkers designed to improve the prognosis and management of cardiac diseases. The company's novel biomarkers conducts miRNA and protein-based research from the clinical samples that is used to distinguish between the different heart failure subtypes and optimally assess the clinical condition of a heart failure patient, enabling medical practitioners to engage into a quick and simplified diagnostic procedure that leads to a better understanding of the cardiovascular status resulting in better treatment decisions and improved patient outcomes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • Meibergdreef 39
  • 1105 AZ Amsterdam
  • Netherlands
+31 020 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ACS Biomarker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 Completed Out of Business
1. Early Stage VC 01-Jan-2011 Completed Generating Revenue
To view ACS Biomarker’s complete valuation and funding history, request access »

ACS Biomarker Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel biomarkers designed to improve the prognosis and management of cardiac diseases. The company's novel
Biotechnology
Amsterdam, Netherlands
6 As of 2016
00000000 00

00000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000000000000
Cambridge, MA
0000 As of 0000
00000
000000000 00000

000000 0

or in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint o
0000 000000000
Sarasota, FL
00 As of 0000
00000
0000 0000-00-00
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACS Biomarker Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bluebird Bio Formerly VC-backed Cambridge, MA 0000 00000 000000000 00000
000000 00000000000 Venture Capital-Backed Sarasota, FL 00 00000 0000000000 0 00000
00000000 000000000 Formerly VC-backed Waltham, MA 0 000.00 000000&0 000.00
00000000 Formerly VC-backed South San Francisco, CA 00 00000 000000&0
To view ACS Biomarker’s complete competitors history, request access »

ACS Biomarker Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial